A Study to Evaluate Mindfulness Intervention During Radiotherapy


About this study

The purpose of this study is to evaluate the effectiveness of a mindfulness-based intervention (MBI) on subjective reports of wellness including emotional, physical, functional, and social domains during radiotherapy for the treatment of cancer.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Age ≥ 18 years old.
  • Prescribed a course of at least 15 daily fractions of RT for curative intent of any malignancy.
  • Willing to attend mindfulness-based intervention (MBI) sessions weekly during RT.
  • Able to transport themselves to scheduled MBI sessions in the Dan Abraham Healthy Living Center (DAHLC).
  • Able to complete questionnaire(s) by themselves.
  • Native English speaker (MBI sessions, videos, and QOL questionnaires are only available in English).
  • ECOG Performance Status 0-2.

Exclusion Criteria:

  • Prescribed a course of RT with fewer than 15 consecutive, daily fractions.
  • Unable or unwilling to attend required MBI sessions.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Kimberly Corbin, M.D.

Open for enrollment

Contact information:

Jennifer Haen

(507) 293-2668


More information


Publications are currently not available

Additional contact information

Cancer-related trials contact form

Phone: 855-776-0015 (toll-free)

International patient clinical studies questions